Compounds > carbidopa, levodopa drug combination
Page last updated: 2024-08-26

carbidopa, levodopa drug combination and Depression

carbidopa, levodopa drug combination has been researched along with Depression in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamed, M; Lazarescu, A; Shetty, A; Suchowersky, O; Tremain, G1
Bellante, F; Dethy, S; Zegers de Beyl, D1
Chigir', IP; Fedorova, NV1
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ1

Other Studies

4 other study(ies) available for carbidopa, levodopa drug combination and Depression

ArticleYear
A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa.
    Parkinsonism & related disorders, 2019, Volume: 61

    Topics: Antiparkinson Agents; Carbidopa; Depression; Drug Combinations; Female; Gels; Humans; Hypoventilation; Infusions, Parenteral; Jejunostomy; Levodopa; Middle Aged; Parkinsonian Disorders

2019
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy.
    Acta neurologica Belgica, 2016, Volume: 116, Issue:1

    Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors

2016
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6

    Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome

2006
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
    Neurology, 1982, Volume: 32, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine

1982